368 results on '"Driessen, Ann"'
Search Results
2. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
3. Zonated quantification of immunohistochemistry in normal and steatotic livers
4. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
5. Author Correction: Organ-specific genome diversity of replication-competent SARS-CoV-2
6. Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy
7. THU-249 The role of the ferroptosis brake glutathione peroxidase 4 in a preclinical model of metabolic dysfunction-associated steatohepatitis
8. WED-281-YI A non-invasive score model for prediction of significant fibrosis and fibrotic metabolic dysfunction-associated steatohepatitis based on serum biomolecules
9. SAT-337 Serum levels of IgA inform on the transcriptomic architecture of the liver and predict hepatocellular carcinoma in chronic viral hepatitis patients
10. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia
11. Dysplasia in Inflammatory Bowel Disease
12. Organ-specific genome diversity of replication-competent SARS-CoV-2
13. Ischemic Colitis
14. Ischemic Bowel Disease
15. Ulcerative Colitis
16. Neutropenic Colitis
17. Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats
18. Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
19. Belgian consensus for Helicobacter pylori management 2023
20. Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper.
21. Unravelling the role of iron-catalysed ferroptotic cell death in non-alcoholic steatohepatitis
22. Data from Simple Clinical Risk Score Identifies Patients with Serrated Polyps in Routine Practice
23. Supplementary Table 2 from Simple Clinical Risk Score Identifies Patients with Serrated Polyps in Routine Practice
24. Supplementary Table 1 from Simple Clinical Risk Score Identifies Patients with Serrated Polyps in Routine Practice
25. Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study
26. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on 99mTc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?
27. Supplementary Table 2 from A Prospective Cohort Study on Overweight, Smoking, Alcohol Consumption, and Risk of Barrett's Esophagus
28. Supplementary Table 3 from A Prospective Cohort Study on Overweight, Smoking, Alcohol Consumption, and Risk of Barrett's Esophagus
29. Supplementary Table 1 from A Prospective Cohort Study on Overweight, Smoking, Alcohol Consumption, and Risk of Barrett's Esophagus
30. Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012
31. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
32. Selective abdominal venous congestion induces adverse renal and hepatic morphological and functional alterations despite a preserved cardiac function
33. Zonated quantification of immunohistochemistry in steatotic livers
34. Is there a murine model that fully recapitulates human NASH? An unbiased bioinformatics approach to rank pre-clinical models based on proximity to human disease
35. Endoscopic Resection of Two Rare Esophageal Tumors
36. Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
37. Toenail selenium status and the risk of Barrett's esophagus: the Netherlands Cohort Study
38. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
39. Total Cancer Incidence and Overall Mortality Are Not Increased Among Patients With Barrett's Esophagus
40. An accidental finding of a giant intra-abdominal mass
41. The histopathological approach to inflammatory bowel disease: a practice guide
42. An accidental finding of a giant intra-abdominal mass.
43. In Vivo Diagnosis and Classification of Colorectal Neoplasia by Chromoendoscopy-Guided Confocal Laser Endomicroscopy
44. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy
45. Hyaluronic Acid as a Marker of Hepatic Sinusoidal Obstruction Syndrome Secondary to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases
46. The Evolution of COVID-19: A Minimal Invasive Autopsy Cohort Studying in Depth the Different COVID- 19 Disease Stages
47. ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease
48. Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity
49. ECCO topical review optimising reporting in surgery, endoscopy, and histopathology collaboration between S-ECCO, EduCom, H-ECCO
50. Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.